Several studies have demonstrated that increased TOP2A expression in glioma cells is strongly associated with tumor metastasis and reduced survival in patients with glioma and that TOP2A is a prominent Wnt pathway activator in glioma, boosting cell growth, motility, and penetration25,39. The gene discussed is TOP2A; the disease is central nervous system cancer.